Director at Cadre Holdings (CDRE) receives 17,393 stock options grant

Rhea-AI Filing Summary

Cadre Holdings director Nicolas Sokolow received a grant of stock options to buy 17,393 shares of common stock at an exercise price of $28.75 per share. These options expire on June 16, 2036 and were issued under the company’s 2021 Stock Incentive Plan.

According to the vesting schedule, options for 4,349 shares will vest and become exercisable on June 30, 2026. Additional tranches of 4,348 options will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SOKOLOW NICOLAS

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to purchase)	17,393	$0.00	--

Holdings After Transaction: Stock Option (right to purchase) — 17,393 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 17,393 options Exercise price: $28.75 per share Expiration date: June 16, 2036 +3 more

6 metrics

Options granted 17,393 options Grant to director Nicolas Sokolow

Exercise price $28.75 per share Stock option exercise price

Expiration date June 16, 2036 Option expiration

First vesting tranche 4,349 options Vest on June 30, 2026

Subsequent vesting tranches 3 × 4,348 options Vest on Sep 30, 2026; Dec 31, 2026; Mar 31, 2027

Transaction code A Grant, award, or other acquisition

Key Terms

Stock Option, 2021 Stock Incentive Plan, exercise price, vesting, +1 more

5 terms

Stock Option financial

"The option to purchase shares of Cadre Holdings, Inc. common stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

2021 Stock Incentive Plan financial

"was granted under the Issuer's 2021 Stock Incentive Plan"

exercise price financial

"conversion_or_exercise_price": "28.7500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"Options to purchase 4,349 shares ... will vest and become exercisable"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"Issuer's Common Stock will vest and become exercisable"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/18/2026 - 04:19 PM Accepted by SEC EDGAR 06/18/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOKOLOW NICOLAS

(Last) (First) (Middle)

C/O CADRE HOLDINGS, INC.

13386 INTERNATIONAL PKWY

(Street)

JACKSONVILLE FLORIDA 32218

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to purchase)	$28.75	06/16/2026		A		17,393		(1)	06/16/2036	Common Stock	17,393	$0	17,393	D

Explanation of Responses:

1. The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.

	/s/ Nicolas Sokolow	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cadre Holdings (CDRE) report for Nicolas Sokolow?

Cadre Holdings reported that director Nicolas Sokolow received a grant of stock options covering 17,393 shares. These options were awarded as compensation, not purchased in the market, and give him the right to buy common stock at a fixed exercise price of $28.75 per share.

What is the size and exercise price of the new Cadre Holdings (CDRE) stock options?

The grant to director Nicolas Sokolow covers 17,393 stock options with an exercise price of $28.75 per share. This means he can buy Cadre Holdings common shares at that price once options vest and he chooses to exercise them before the June 16, 2036 expiration.

How do the Cadre Holdings (CDRE) options granted to Nicolas Sokolow vest over time?

The options vest in four installments between 2026 and 2027. 4,349 options vest on June 30, 2026, and 4,348 options vest on each of September 30, 2026, December 31, 2026, and March 31, 2027, subject to the plan’s terms and continued service conditions.

Did Nicolas Sokolow buy or sell any Cadre Holdings (CDRE) shares in this Form 4?

The Form 4 reports only a grant of stock options to Nicolas Sokolow and no open-market buys or sells. The transaction code is "A," indicating a grant or award acquisition, so it reflects compensation rather than a discretionary stock purchase or sale.

Under which plan were the Cadre Holdings (CDRE) options granted to Nicolas Sokolow?

The options were granted under Cadre Holdings’ 2021 Stock Incentive Plan. This plan provides equity-based compensation, such as stock options, to directors and other eligible participants, aligning their interests with shareholders through potential future ownership of the company’s common stock.

When do the newly granted Cadre Holdings (CDRE) options to Nicolas Sokolow expire?

The stock options granted to Nicolas Sokolow expire on June 16, 2036, if not exercised earlier. He may exercise vested options any time before that expiration date, subject to the plan’s rules and any applicable service or termination provisions described in the incentive plan.